Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy

Randomized pharmacokinetic study comparing subcutaneous and intravenous palonosetron in cancer patients treated with platinum based chemotherapy

BACKGROUND: Palonosetron is a potent second generation 5- hydroxytryptamine-3 selective antagonist which can be administered by either intravenous (IV) or oral routes, but subcutaneous (SC) administration of palonosetron has never been studied, even though it could have useful clinical applicatio...

Full description

Bibliographic Details
Main Authors: Sadaba, B. (Belén), Barrio, A. (Anabel) del, Campanero, M.A. (Miguel Angel), Azanza, J.R. (José Ramón), Gomez-Guiu, A. (Almudena), Lopez-Picazo, J.M. (José M.), Martin-Algarra, S. (Salvador), Guillen-Grima, F. (Francisco), Blanco-Prieto, M.J. (María José), Perez-Gracia, J.L. (Jose Luis), Gurpide, A. (Alfonso)
Format: info:eu-repo/semantics/article
Language:eng
Published: Public Library of Science 2014
Subjects:
Palonosetron
Oral chemotherapy
Administration
Online Access:https://hdl.handle.net/10171/35520

Internet

https://hdl.handle.net/10171/35520

Similar Items